141 related articles for article (PubMed ID: 33914737)
1. Loss-of-function of Fbxo10, encoding a post-translational regulator of BCL2 in lymphomas, has no discernible effect on BCL2 or B lymphocyte accumulation in mice.
Masle-Farquhar E; Russell A; Li Y; Zhu F; Rui L; Brink R; Goodnow CC
PLoS One; 2021; 16(4):e0237830. PubMed ID: 33914737
[TBL] [Abstract][Full Text] [Related]
2. Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma.
Chiorazzi M; Rui L; Yang Y; Ceribelli M; Tishbi N; Maurer CW; Ranuncolo SM; Zhao H; Xu W; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Delabie J; Rimsza LM; Shaham S; Staudt LM
Proc Natl Acad Sci U S A; 2013 Mar; 110(10):3943-8. PubMed ID: 23431138
[TBL] [Abstract][Full Text] [Related]
3. Functional Implications of the spectrum of BCL2 mutations in Lymphoma.
Singh K; Briggs JM
Mutat Res Rev Mutat Res; 2016; 769():1-18. PubMed ID: 27543313
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated TRAF3 and BCL2 Expression Promotes Multiple Classes of Mature Non-hodgkin B Cell Lymphoma in Mice.
Perez-Chacon G; Adrados M; Vallejo-Cremades MT; Lefebvre S; Reed JC; Zapata JM
Front Immunol; 2018; 9():3114. PubMed ID: 30687320
[TBL] [Abstract][Full Text] [Related]
5. Recent BCR stimulation induces a negative autoregulatory loop via FBXO10 mediated degradation of HGAL.
Guo F; Luo Y; Jiang X; Lu X; Roberti D; Lossos C; Kunkalla K; Magistri M; Rui L; Verdun R; Vega F; Moy VT; Lossos IS
Leukemia; 2020 Feb; 34(2):553-566. PubMed ID: 31570756
[TBL] [Abstract][Full Text] [Related]
6. FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma.
Li Y; Bouchlaka MN; Wolff J; Grindle KM; Lu L; Qian S; Zhong X; Pflum N; Jobin P; Kahl BS; Eickhoff JC; Wuerzberger-Davis SM; Miyamoto S; Thomas CJ; Yang DT; Capitini CM; Rui L
Oncogene; 2016 Dec; 35(48):6223-6234. PubMed ID: 27157620
[TBL] [Abstract][Full Text] [Related]
7. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
[TBL] [Abstract][Full Text] [Related]
8. B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice.
Knittel G; Liedgens P; Korovkina D; Seeger JM; Al-Baldawi Y; Al-Maarri M; Fritz C; Vlantis K; Bezhanova S; Scheel AH; Wolz OO; Reimann M; Möller P; López C; Schlesner M; Lohneis P; Weber AN; Trümper L; ; Staudt LM; Ortmann M; Pasparakis M; Siebert R; Schmitt CA; Klatt AR; Wunderlich FT; Schäfer SC; Persigehl T; Montesinos-Rongen M; Odenthal M; Büttner R; Frenzel LP; Kashkar H; Reinhardt HC
Blood; 2016 Jun; 127(22):2732-41. PubMed ID: 27048211
[TBL] [Abstract][Full Text] [Related]
9. MYC in Germinal Center-derived lymphomas: Mechanisms and therapeutic opportunities.
Bisso A; Sabò A; Amati B
Immunol Rev; 2019 Mar; 288(1):178-197. PubMed ID: 30874346
[TBL] [Abstract][Full Text] [Related]
10. Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma.
Dupont T; Yang SN; Patel J; Hatzi K; Malik A; Tam W; Martin P; Leonard J; Melnick A; Cerchietti L
Oncotarget; 2016 Jan; 7(3):3520-32. PubMed ID: 26657288
[TBL] [Abstract][Full Text] [Related]
11. Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation.
Natkunam Y; Lossos IS; Taidi B; Zhao S; Lu X; Ding F; Hammer AS; Marafioti T; Byrne GE; Levy S; Warnke RA; Levy R
Blood; 2005 May; 105(10):3979-86. PubMed ID: 15677569
[TBL] [Abstract][Full Text] [Related]
12. BCL2 and JUNB abnormalities in primary cutaneous lymphomas.
Mao X; Orchard G; Lillington DM; Child FJ; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
Br J Dermatol; 2004 Sep; 151(3):546-56. PubMed ID: 15377339
[TBL] [Abstract][Full Text] [Related]
13. Synergistic activity of Card11 mutant and Bcl6 in the development of diffuse large B-cell lymphoma in a mouse model.
Takahara T; Matsuo K; Seto M; Nakamura S; Tsuzuki S
Cancer Sci; 2016 Nov; 107(11):1572-1580. PubMed ID: 27560392
[TBL] [Abstract][Full Text] [Related]
14. Non-Hodgkin and Hodgkin Lymphomas Select for Overexpression of BCLW.
Adams CM; Mitra R; Gong JZ; Eischen CM
Clin Cancer Res; 2017 Nov; 23(22):7119-7129. PubMed ID: 28855351
[No Abstract] [Full Text] [Related]
15.
García-Ramírez I; Tadros S; González-Herrero I; Martín-Lorenzo A; Rodríguez-Hernández G; Moore D; Ruiz-Roca L; Blanco O; Alonso-López D; Rivas JL; Hartert K; Duval R; Klinkebiel D; Bast M; Vose J; Lunning M; Fu K; Greiner T; Rodrigues-Lima F; Jiménez R; Criado FJG; Cenador MBG; Brindle P; Vicente-Dueñas C; Alizadeh A; Sánchez-García I; Green MR
Blood; 2017 May; 129(19):2645-2656. PubMed ID: 28288979
[TBL] [Abstract][Full Text] [Related]
16. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
[TBL] [Abstract][Full Text] [Related]
17. VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia.
Egle A; Harris AW; Bath ML; O'Reilly L; Cory S
Blood; 2004 Mar; 103(6):2276-83. PubMed ID: 14630790
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of 'double-hit' and 'double-expression' lymphomas.
Ma Z; Niu J; Cao Y; Pang X; Cui W; Zhang W; Li X
J Clin Pathol; 2020 Mar; 73(3):126-138. PubMed ID: 31615842
[TBL] [Abstract][Full Text] [Related]
19. Role of the cyclic AMP response element in the bcl-2 promoter in the regulation of endogenous Bcl-2 expression and apoptosis in murine B cells.
Xiang H; Wang J; Boxer LM
Mol Cell Biol; 2006 Nov; 26(22):8599-606. PubMed ID: 16982684
[TBL] [Abstract][Full Text] [Related]
20. Cluster analysis of apoptosis-associated bcl2 family proteins in diffuse large B-cell lymphomas. Relations with the apoptotic index, the proliferation profile and the B-cell differentiation immunophenotypes.
Bai M; Skyrlas A; Agnantis NJ; Kamina S; Kitsoulis P; Kanavaros P
Anticancer Res; 2004; 24(5A):3081-8. PubMed ID: 15517919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
